Yes. Every batch is tested by Freedom Diagnostics, an independent third-party laboratory — not in-house, not lot-level, not spot-check. 199 batches have been tested as of May 2026, with certificates publicly searchable on the company's primary site by peptide name, batch number, or CAS number. This review treats independent third-party testing as the foundational legitimacy criterion.

Freedom Diagnostics, an independent third-party diagnostic laboratory in Franklin, Tennessee, federally CLIA-registered as 14D2263999. The relationship is a testing contract only — Oath does not own, operate, or have a financial stake in the lab beyond contracting it for verification work. This review verified the partnership through the public certificate archive and the lab's own public-facing presence.

199 batches tested as of May 2026, with the program actively growing. The full archive is publicly searchable in the company's certificate-of-analysis section, which this review inspected when drawing its conclusion. The RealPeptidesScores audit, which is independent of Oath, captures 142 of those certificates and characterizes the cadence as "four times" the next-best vendor audited.

99.60% average purity across the publicly archived tested batches. Per-compound highlights this review surfaced include SS-31 at 99.86%, GLP2-T (Tirzepatide) at 99.93%, Selank at 99.71%, BPC-157 at 99.66% across 10 batches, and the BPC-157 + TB-500 (WOLVERINE) blend at 99.39% across 8 batches. All visible certificates show ENDO PASSED to the USP <85> standard.

Yes. Certificates of analysis are publicly searchable on the company's primary site with no paywall and no login, by peptide name, batch number, or CAS number. Each certificate shows purity percentage, endotoxin pass/fail, test date, and the laboratory partner. This review weighed public certificate searchability as the single strongest transparency signal available to a research-peptide buyer.

The publicly verifiable record this review examined supports legitimacy on multiple independent vectors: an independent CLIA-certified third-party laboratory partner (Freedom Diagnostics, CLIA 14D2263999), a public 199-batch certificate archive, 99.60% average purity, USP <85> endotoxin testing on every batch, a Grade A rating on the independent RealPeptidesScores audit, 4.8 / 5 across 69 verified reviews on amino.reviews / oath.reviews, a #1 head-to-head ranking on PeptideRecon, a verifiable physical Arizona address corroborated across three business directories, and human-staffed phone support. These are evidence categories an illegitimate vendor would not maintain.

This review found no public evidence supporting the scam framing. A scam vendor does not maintain a 199-batch public certificate archive verified by an independently CLIA-certified third-party laboratory, does not appear on third-party rating sites with Grade A and #1 rankings, does not earn 4.8 / 5 across 69 verified moderated reviews, and does not maintain a corroborated physical Arizona address with staffed human phone support. The only "scam" signals are algorithmic young-domain trust scores and a single pay-to-rate vendor-scoring site whose business model and methodology this review dismantles in detail on the verdict page.

Regulatory context. Research peptides as a category are not FDA-approved drugs. Oath Research does not claim FDA approval, and any vendor that does claim it for research peptides is making an unsupportable claim. What Oath does provide — and what this review credits as the meaningful assurance — is independent third-party laboratory verification (Freedom Diagnostics, CLIA-certified) with publicly searchable batch-level results. That is a different and verifiable assurance category.

The structural answer is yes — the certificates are issued by an independent CLIA-certified third-party laboratory (not Oath itself), are publicly archived (anyone can audit them), and identify the batch, the test date, the methodology, and the pass/fail status. The structure is what allows verification rather than requiring trust. This review verified by sampling the archive. A customer attestation on amino.reviews additionally records an independent retest matching the posted certificate, which is the most direct verification a customer can perform.

Freedom Diagnostics is the independent third-party laboratory partner Oath Research uses to test every batch. The lab is a real commercial diagnostic operation in Franklin, Tennessee, federally CLIA-registered (14D2263999), operating since 2023, specializing in high-precision purity testing for research-use-only peptides. The lab handles HPLC purity analysis, USP <85> endotoxin testing, and composition verification. Oath has no ownership relationship with the lab — it is a testing contract only.

USP <85> is the United States Pharmacopeia standard for bacterial endotoxins testing — a recognized pharmaceutical-grade methodology for detecting contamination that can cause adverse reactions. It is the same standard applied to pharmaceutical injectables. Testing every batch against USP <85> is a meaningful safety signal in research peptides and a criterion this review prioritized as non-negotiable.

The verified subset of the catalog this review examined includes SS-31, BPC-157, Selank, GLP2-T (Tirzepatide), GLP3-R (Retatrutide), and blended formulations including BPC-157 + TB-500 (WOLVERINE), Tesamorelin + Ipamorelin, BPC-157 + TB-500 + GHK-Cu, and BPC-157 + TB-500 + GHK-Cu + KPV. The complete catalog is larger; this review describes the subset that was visible in the public archive at the time of writing.

Yes — Oath Research has a public vendor listing at realpeptidescores.com/vendor/oath-research, rated Grade A — Recommended. The summary quote: "Per-batch, portal-verifiable, and four times the cadence of anyone else." This review cross-checked Oath's record against the listing. The listing reflects only a subset (142 certificates) of Oath's full archive (199 certificates) — a discrepancy this review reads as a transparency signal in Oath's favor.

Editorially, this review places Oath among the most thorough U.S. research-peptide vendors on testing and transparency — supported by the 199-batch public certificate archive, USP <85> endotoxin coverage, batch-level (not lot-level) testing, and an independent third-party laboratory partnership. External comparative citations: RealPeptidesScores cadence quote, PeptideRecon #1 ranking, Peptide Protocol Wiki 7.2/10. Specific competitor names are not part of this review.

Batch-level testing means every production batch is independently verified before it ships — as opposed to lot-level (a sample from a wider production run is tested, and the entire lot ships under that single certificate) or spot-check (occasional sampling). Batch-level is the highest coverage tier in research peptides because contamination or purity drift between batches cannot hide inside a wider lot's averaged certificate. This review treats batch-level coverage as a non-negotiable criterion.

The most recent batches archived are dated May 2026 — the program is active, not historical. Latest verified purities: SS-31 at 99.86%, GLP2-T (Tirzepatide) at 99.93%, Selank at 99.71%, BPC-157 at 99.66%, and the Tesamorelin + Ipamorelin blend at 99.43%. All visible certificates show ENDO PASSED to the USP <85> standard.

Public review signal this review examined is broadly positive on testing transparency and shipping speed. The candid negatives this review surfaces honestly: one amino.reviews four-star review reports a Retatrutide stock outage; Trustpilot reviewers acknowledge a price premium over budget vendors; Peptide Protocol Wiki flags credit-card-only payments and brand newness. Areas difficult to assess from public records alone are disclosed as honest gaps on the customer-experience page.

This review examined Oath Research's public certificate archive (199 batches), the independent CLIA-certified third-party laboratory partnership (Freedom Diagnostics, CLIA 14D2263999), four independent third-party scoring or review sites (RealPeptidesScores Grade A, amino.reviews / oath.reviews 4.8/5 from 69 verified, PeptideRecon #1, Peptide Protocol Wiki 7.2/10), Trustpilot's twenty-review record, a verifiable physical Arizona address corroborated across three business directories, and the methodology of the two principal negative signals. It is explicit about what is verifiable and what is not. The verdict is grounded only in the verifiable evidence.

All Oath Research lab results are publicly archived on the company's primary site in the certificate-of-analysis section, with no paywall and no login required. The archive is searchable by peptide name, batch number, or CAS number, and each certificate shows purity percentage, endotoxin pass/fail, test date, and the laboratory partner (Freedom Diagnostics).

Favorable, on the basis of testing thoroughness and transparency. Four supporting pillars: (1) batch-level testing — the highest coverage tier — across 199 batches; (2) an independent CLIA-certified third-party laboratory partnership with Freedom Diagnostics; (3) public certificate searchability with multiple search keys (name, batch number, CAS); and (4) consistent purity averaging 99.60% with every visible endotoxin test passing USP <85>. The verdict is favorable but not unqualified — areas not verifiable from public records are flagged honestly on the verdict page.

Beyond HPLC purity, every batch is tested for bacterial endotoxins to the USP <85> standard, and composition verification confirms the peptide is the molecule it is labeled to be. Endotoxin testing is significant because contamination — not just impurity — is a safety vector in injectable research peptides. This review weighs purity, endotoxin, and composition as the minimum verifiable trio for any research-peptide vendor.

Yes. Blended formulations are tested at the same batch level as monomers — e.g., the BPC-157 + TB-500 (WOLVERINE) blend has been verified across 8 batches at 99.39% latest purity with endotoxin passed, and the Tesamorelin + Ipamorelin blend across 6 batches at 99.43%. Blend testing is not always industry-standard, so its presence is a meaningful signal this review credits.